Family history and risk of ductal carcinoma in situ and triple negative breast cancer in a Han Chinese population: a case–control study
详细信息 查看全文
- 作者：Wenbin Zhou (8)
Hong Pan (8)
Mengdi Liang (8)
Kai Xia (8) (9)
Xiuqing Liang (8)
Jinqiu Xue (8)
Lin Cheng (8)
Jialei Xue (8)
Si Chen (8)
Xiaoan Liu (8)
Qiang Ding (8)
Lijun Ling (8)
Shui Wang (8) - 关键词：Case–control ; Ductal carcinoma in situ ; Family history ; Triple negative breast cancer
- 刊名：World Journal of Surgical Oncology
- 出版年：2013
- 出版时间：December 2013
- 年：2013
- 卷：11
- 期：1
- 全文大小：177 KB
- 参考文献：1. Yu ZG, Jia CX, Liu LY, Geng CZ, Tang JH, Zhang J, Zhang Q, Li YY, Ma ZB: The prevalence and correlates of breast cancer among women in Eastern China. / PLoS One 2012,7(6):e37784. CrossRef
2. Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. / J Clin Oncol 2006,24(14):2137-150. CrossRef
3. Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI: Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk. / Breast Cancer Res Treat 2011,126(3):671-78. CrossRef
4. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM: Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. / Clin Cancer Res 2004,10(16):5367-374. CrossRef
5. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA: Triple-negative breast cancer: clinical features and patterns of recurrence. / Clin Cancer Res 2007,13(15 Pt 1):4429-434. CrossRef
6. Rodriguez-Pinilla SM, Sarrio D, Honrado E, Hardisson D, Calero F, Benitez J, Palacios J: Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. / Clin Cancer Res 2006,12(5):1533-539. CrossRef
7. Ready K, Arun B: Clinical assessment of breast cancer risk based on family history. / J Natl Compr Canc Netw 2010,8(10):1148-155.
8. Zhou WB, Xue DQ, Liu XA, Ding Q, Wang S: The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis. / J Cancer Res Clin Oncol 2011,137(7):1053-060. CrossRef
9. Collaborative Group on Hormonal Factors in Breast Cancer: Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. / Lancet 2001,358(9291):1389-399. CrossRef
10. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA: Family history and the risk of breast cancer: a systematic review and meta-analysis. / Int J Cancer 1997,71(5):800-09. CrossRef
11. Anderson H, Bladstrom A, Olsson H, Moller TR: Familial breast and ovarian cancer: a Swedish population-based register study. / Am J Epidemiol 2000,152(12):1154-163. CrossRef
12. Negri E, Braga C, La Vecchia C, Franceschi S, Parazzini F: Family history of cancer and risk of breast cancer. / Int J Cancer 1997,72(5):735-38. CrossRef
13. Millikan RC, Newman B, Tse C-K, Moorman PG, Conway K, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM: Epidemiology of basal-like breast cancer. / Breast Cancer Res Treat 2008,109(1):123-39. CrossRef
14. Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Anderson WF, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Cartun R, Mandich D, Rymkiewicz G, Ligaj M, Lukaszek S, Kordek R, García-Closas M: Differences in risk factors for breast cancer molecular subtypes in a population-based study. / Cancer Epidemiol Biomarkers Prev 2007,16(3):439-43. CrossRef
15. Jiang X, Castelao JE, Chavez-Uribe E, Fernandez Rodriguez B, Celeiro Mu?oz C, Redondo CM, Pe?a Fernandez M, Novo Dominguez A, Pereira CD, Martínez ME, García-Caballero T, Fraga Rodriguez M, Antúnez J, Carracedo A, Forteza-Vila J, Gago-Dominguez M: Family history and breast cancer hormone receptor status in a Spanish cohort. / PLoS One 2012,7(1):e29459. CrossRef
16. Li CI, Malone KE, Daling JR: Differences in breast cancer stage, treatment, and survival by race and ethnicity. / Arch Intern Med 2003,163(1):49-6. CrossRef
17. Shavers VL, Harlan LC, Stevens JL: Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. / Cancer 2003,97(1):134-47. CrossRef
18. Chu KC, Anderson WF: Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. / Breast Cancer Res Treat 2002,74(3):199-11. CrossRef
19. Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW: Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. / Cancer 2001,92(1):37-5. CrossRef
20. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC: Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. / JAMA 2006,295(21):2492-502. CrossRef
21. Virnig BA, Wang SY, Shamilyan T, Kane RL, Tuttle TM: Ductal carcinoma in situ : risk factors and impact of screening. / J Natl Cancer Inst Monogr 2010,2010(41):113-16. CrossRef
22. Claus EB, Stowe M, Carter D: Breast carcinoma in situ : risk factors and screening patterns. / J Natl Cancer Inst 2001,93(23):1811-817. CrossRef
23. Claus EB, Stowe M, Carter D: Family history of breast and ovarian cancer and the risk of breast carcinoma in situ . / Breast Cancer Res Treat 2003,78(1):7-5. CrossRef
24. Trentham-Dietz A, Newcomb PA, Storer BE, Remington PL: Risk factors for carcinoma in situ of the breast. / Cancer Epidemiol Biomarkers Prev 2000,9(7):697-03.
25. Kerlikowske K, Barclay J, Grady D, Sickles EA, Ernster V: Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. / J Natl Cancer Inst 1997,89(1):76-2. CrossRef
26. Zhou W, He Z, Xue J, Wang M, Zha X, Ling L, Chen L, Wang S, Liu X: Molecular subtype classification is a determinant of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes. / PLoS One 2012,7(4):e35881. CrossRef
27. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF, American Society of Clinical Oncology: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. / J Clin Oncol 2007,25(1):118-45. CrossRef
28. Yin WJ, Lu JS, Di GH, Lin YP, Zhou LH, Liu GY, Wu J, Shen KW, Han QX, Shen ZZ, Shao ZM: Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients. / Breast Cancer Res Treat 2009,115(2):325-33. CrossRef
29. Reyal F, Rouzier R, Depont-Hazelzet B, Bollet MA, Pierga JY, Alran S, Salmon RJ, Fourchotte V, Vincent-Salomon A, Sastre-Garau X, Antoine M, Uzan S, Sigal-Zafrani B, De Rycke Y: The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma. / PLoS One 2011,6(5):e20297. CrossRef
30. Wallis MG, Clements K, Kearins O, Ball G, Macartney J, Lawrence GM: The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS. / Br J Cancer 2012,106(10):1611-617. CrossRef - 作者单位：Wenbin Zhou (8)
Hong Pan (8)
Mengdi Liang (8)
Kai Xia (8) (9)
Xiuqing Liang (8)
Jinqiu Xue (8)
Lin Cheng (8)
Jialei Xue (8)
Si Chen (8)
Xiaoan Liu (8)
Qiang Ding (8)
Lijun Ling (8)
Shui Wang (8)
8. Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China
9. Department of Breast Surgery, The Affiliated Jiangyin Hospital of Southeast University Medical College, 163 Shoushan Road, Jiangyin, 214400, China - ISSN：1477-7819
文摘
Background The association between family history and risk of triple negative breast cancer and ductal carcinoma in situ (DCIS) has not been well investigated, especially in Asian populations. We investigated the association between family history and risk of DCIS or triple negative breast cancer in a Han Chinese population. Methods A case–control study, comprising 926 breast cancer patients and 1,187 benign breast disease controls, was conducted in our hospital. Multivariate logistic regression was used to assess the relationships between family history and risk of DCIS or triple negative breast cancer. Results Subjects with a family history of breast cancer had higher breast cancer risk than those without a family history (odds ratio (OR) = 2.11, 95% confidence interval (CI) = 1.26 to 3.52). Family history was not significantly associated with an increased risk of DCIS (OR = 1.27, 95% CI = 0.36 to 4.46), while family history was significantly associated with an increased risk of invasive breast cancer (OR = 2.22, 95% CI = 1.32 to 3.75), irrespective of triple negative breast cancer (OR = 3.35, 95% CI = 1.43 to 7.88) or non-triple negative breast cancer (OR = 2.14, 95% CI = 1.21 to 3.80). Conclusion Our results indicate that having a family history of breast cancer is associated with an increased risk of triple negative breast cancer with a magnitude of association similar to that for non-triple negative breast cancer. Furthermore, family history is not significantly associated with an increased risk of DCIS. Future cohort studies with larger sample sizes are still needed to explore these relationships.